Nuvation Bio is a global biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differentiated and novel therapeutic candidates. Nuvation Bio’s portfolio of development candidates includes taletrectinib (ROS1), safusidenib (mIDH1), NUV-868 (BET), and NUV-1511 (...
Use this information to figure out if this company is an ideal customer for you.
415.754.3517
1500 Broadway
New York, 10036
Nuvation Bio's CEO is David Hung
Nuvation Bio's CFO is Philippe Sauvage
Nuvation Bio's HQ is located at 1500 Broadway, New York
Nuvation Bio's phone number is 415.754.3517
Nuvation Bio's official website is nuvationbio.com
Nuvation Bio's revenue is $5M - $20M
Nuvation Bio has 201 - 500 employees
Nuvation Bio is in the industry of: Pharmaceuticals